24 April 2020

Dirk Pollet joins Oncode Oncology Bridge Fund as Entrepreneur in Residence

Following Dr. Markwin Velders and Dr. Allard Kaptein joining the Oncode Oncology Bridge Fund as Entrepreneurs in Residence this February, we are happy to announce that Dr. Dirk Pollet now joined the Oncode Oncology Bridge Fund’s team of experienced entrepreneurs.

Bianca-Olivia Nita

Dr. Pollet has a PhD degree in Biochemistry and brings over 25 years of experience in the diagnostics and biotechnology industries. He led Multiplicom NV, a European diagnostics company with state-of-the-art genetic testing technology and products, before this was acquired by Agilent Technologies. Before that, Dr. Pollet served as Chief Business Officer and Board Member at Cellectis SA, as well as in several other senior leading positions for other companies (click for full bio).

In the pre-incorporation phase, Dr. Pollet will be available for consultation with our research groups. Dr. Pollet and the other Entrepreneurs in Residence will provide regular coaching sessions and mentoring support to portfolio companies.

About the Oncode Oncology Bridge Fund
Oncode BV created
the Oncode Oncology Bridge Fund (Bridge Fund) as part of its overall valorization strategy. Its objective is providing early stage capital to support the creation and growth of new enterprises based on excellent science performed by Oncode Researchers and accelerate the translation of innovative cancer research into products and services that benefit patients. The Bridge Fund stands to make a significant impact on the lives of cancer patients. By facilitating the development of new treatment options and diagnostic methods, the Bridge Fund will contribute to improving treatment outcomes for cancer patients all over the world. Please contact Shobhit Dhawan via shobit.dhawan@oncode.nl if you’d like to know more about the Bridge Fund.

Other News

Oncode Coverbeeld Q2 2021
Oncode Digital Magazine - April 2021
Welcome to the April edition of our digital magazine! Discover the latest interviews, science stories, latest updates and much more.
Vesnade Jong

<span>Vesna</span><span>de Jong</span>

Vesna is a Digital Content Manager at Lygature, and is responsible for all things digital at Oncode. Originally from Slovenia, where she finished her MA in English language and literature, life led her to the Netherlands. Vesna has more than 10 years of experience in translation and localization, and has gained extensive experience of digital communications while working for one of the biggest online travel agencies.
Lude and Michiel
Oncode Investigators Michiel Vermeulen and Lude Franke receive Vici grant
Oncode is proud to announce that Oncode Investigators Michiel Vermeulen (Radboudumc) and Lude Franke (UMCG) will both receive the Vici grant of 1.5 million euros from the Dutch Research Council (NWO).
PeterThijssen
Ecto org KRT14
First patient-derived organoid model for cervical cancer
Researchers from the group of Oncode Investigator Hans Clevers (Hubrecht Institute) developed the first patient-derived organoid model for cervical cancer. They also modelled the healthy human cervix using organoids. In close collaboration with the UMC Utrecht, Princess Máxima Center for pediatric oncology and the Netherlands Cancer Institute, the researchers used the organoid-based platform to study sexually transmitted infections for a herpes virus. The model can potentially also be used to study the human papillomavirus (HPV), which is one of the main causes of cervical cancer.
Bianca-OliviaNita